Brief: Egetis Therapeutics Q1 Loss SEK 94.5 Mln

Egetis Therapeutics AB (publ)

29/04/2026 06:12

April 29 (Reuters) - Egetis Therapeutics AB (publ) EGTX.ST:

EGETIS THERAPEUTICS Q1 REVENUE SEK 13.4 MILLION

EGETIS THERAPEUTICS Q1 ADJUSTED EPS SEK -0.2

Q1 LOSS MSEK -94.5 (-62.9)

Source text: ID:nMFN145NVv

Further company coverage: EGTX.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))